Literature DB >> 2793706

Aminophylline effects on ventilatory response to hypoxia and hyperoxia in normal adults.

D Georgopoulos1, S G Holtby, D Berezanski, N R Anthonisen.   

Abstract

In 10 normal young adults, ventilation was evaluated with and without pretreatment with aminophylline, an adenosine blocker, while they breathed pure O2 1) after breathing room air and 2) after 25 min of isocapnic hypoxia (arterial O2 saturation 80%). With and without aminophylline, 5 min of hyperoxia significantly increased inspiratory minute ventilation (VI) from the normoxic base line. In control experiments, with hypoxia, VI initially increased and then declined to levels that were slightly above the normoxic base line. Pretreatment with aminophylline significantly attenuated the hypoxic ventilatory decline. During transitions to pure O2 (cessation of carotid bodies' output), VI and breathing patterns were analyzed breath by breath with a moving-average technique, searching for nadirs before and after hyperoxia. On placebo days, at the end of hypoxia, hyperoxia produced nadirs that were significantly lower than those observed with room-air breathing and also significantly lower than when hyperoxia followed normoxia, averaging, respectively, 6.41 +/- 0.52, 8.07 +/- 0.32, and 8.04 +/- 0.39 (SE) l/min. This hypoxic depression was due to significant decrease in tidal volume and prolongation of expiratory time. Aminophylline partly prevented these alterations in breathing pattern; significant posthypoxic ventilatory depression was not observed. We conclude that aminophylline attenuated hypoxic central depression of ventilation, although it does not affect hyperoxic steady-state hyperventilation. Adenosine may play a modulatory role in hypoxic but not in hyperoxic ventilation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793706     DOI: 10.1152/jappl.1989.67.3.1150

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  N Duffy; P Walker; F Diamantea; P M A Calverley; L Davies
Journal:  Thorax       Date:  2005-06-06       Impact factor: 9.139

Review 2.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 3.  Cheyne-stokes respiration in patients with heart failure.

Authors:  Laila AlDabal; Ahmed S BaHammam
Journal:  Lung       Date:  2009-12-03       Impact factor: 2.584

4.  Plasma adenosine during investigation of hypoxic ventilatory response.

Authors:  Dirk Drumm; Markus Hoefer; Janos Juhász; Eva Huszár; Gerhard W Sybrecht
Journal:  Sleep Breath       Date:  2004-03       Impact factor: 2.816

Review 5.  The O2-sensitive brain stem, hyperoxic hyperventilation, and CNS oxygen toxicity.

Authors:  Jay B Dean; Nicole M Stavitzski
Journal:  Front Physiol       Date:  2022-07-26       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.